Hangzhou Polymed Biopharmaceuticals

Private

HangzhouHealthcare & Life Scienceshttps://polymedbiopharma.com/en

Last Round

VC Round

Dec 12, 2022

Company Overview

Hangzhou Polymed Biopharmaceuticals is a biopharmaceutical company that focuses on the discovery and development of novel therapies for oncology and autoimmune diseases using protein degradation technologies and small molecule inhibitors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

proteolysis targeting chimeraPROTACprotein degraderdegrader antibody conjugateDACtargeted protein degradationAI drug discoveryAIDDstructural biologyundruggable targetsbiopharmaceuticaldrug pipelinesmall molecule inhibitorprecision medicinenext-gen therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hangzhou Polymed Biopharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Hangzhou Polymed Biopharmaceuticals comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hangzhou Polymed Biopharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Dec 12, 2022
VC Round	Jul 30, 2021

View all Funding Rounds

Hangzhou Polymed Biopharmaceuticals Investors

Notable investors and investment history

Hangzhou Polymed Biopharmaceuticals investors
Investor	Rounds
Cybernaut Investment Group	VC Round
ZJKF Capital Management	VC Round
MPC	VC Round

View all Investors

Hangzhou Polymed Biopharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Hangzhou Polymed Biopharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hangzhou Polymed Biopharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou

Employee Range7

Year Founded2018

Last FundingDec 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.